RAY RUSSELL T
Insider CIK 1225960 · MACK Director · TNDM 10% owner · ATNF Director · AGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNF 180 Life Sciences Corp. | A Award deriv | 2023-09-04 | 2023-09-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2023-09-04 | 2023-09-08 | 21,455 | $1.36 | $29.2K | 24,409 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2022-10-31 | 2022-11-02 | 30,702 | — | $0 | 59,068 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2022-07-27 | 2022-07-29 | 13,068 | — | $0 | 28,366 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2022-05-19 | 2022-07-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2022-05-19 | 2022-07-29 | 10,570 | $1.36 | $14.4K | 15,298 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2022-05-19 | 2022-05-23 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2022-05-19 | 2022-05-23 | 10,570 | $1.36 | $14.4K | 10,570 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2022-01-14 | 2022-01-18 | 4,728 | $3.04 | $14.4K | 4,728 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | S Sale | 2021-12-31 | 2022-01-04 | 1,000 | $3.84 | $3.8K | 0 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2021-08-04 | 2021-08-05 | 79,000 | — | $0 | 79,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2021-06-10 | 2021-06-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2020-07-30 | 2020-08-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2019-10-17 | 2019-10-21 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2018-06-13 | 2018-06-15 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2017-09-13 | 2017-09-15 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2016-06-14 | 2016-06-16 | 43,000 | — | $0 | 43,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2015-05-13 | 2015-05-18 | 19,063 | — | $0 | 19,063 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 11,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 11,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 11,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 4,305 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 11,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 9,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 27,167 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2014-05-06 | 2014-05-08 | 4,305 | $166.32 | $716.0K | 4,305 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2014-05-06 | 2014-05-08 | 1,249 | — | $0 | 27,167 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 374,805 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 2,061,616 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-21 | 1,454,058 | — | $0 | 1,454,058 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | P Buy | 2013-11-13 | 2013-11-14 | 200,000 | $15.00 | $3.00M | 200,000 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2013-04-30 | 2013-05-02 | 3,102 | — | $0 | 25,912 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-21 | 2012-11-26 | 5,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-21 | 2012-11-26 | 5,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-21 | 2012-11-26 | 5,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-11-21 | 2012-11-26 | 18,000 | $91.05 | $1.64M | 22,800 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-21 | 2012-11-26 | 5,000 | $36.49 | $182.4K | 37,800 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-21 | 2012-11-26 | 5,000 | $45.89 | $229.4K | 32,800 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-21 | 2012-11-26 | 5,000 | $36.85 | $184.3K | 27,800 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-11-21 | 2012-11-26 | 15,000 | $91.05 | $1.37M | 22,800 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-05-01 | 2012-05-02 | 4,800 | — | $0 | 40,800 | SEC↗ |